Total Payments
$65,689
2024 Payments
$5,057
Companies
36
Transactions
296
Medicare Patients
9,199
Medicare Billing
$1.1M
Payment Breakdown by Category
Other$31,875 (48.5%)
Consulting$14,078 (21.4%)
Research$11,359 (17.3%)
Food & Beverage$7,329 (11.2%)
Travel$874.63 (1.3%)
Education$173.56 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $31,875 | 16 | 48.5% |
| Consulting Fee | $14,078 | 7 | 21.4% |
| Unspecified | $11,359 | 15 | 17.3% |
| Food and Beverage | $7,329 | 252 | 11.2% |
| Travel and Lodging | $874.63 | 2 | 1.3% |
| Education | $173.56 | 4 | 0.3% |
Payments by Type
General
$54,330
281 transactions
Research
$11,359
9 transactions
Ownership
$0
6 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | $26,647 | 37 | $0 (2024) |
| Celgene Corporation | $15,684 | 29 | $0 (2018) |
| LEO Pharma AS | $7,768 | 4 | $0 (2018) |
| Dr.Reddy's Laboratories,Inc. | $3,512 | 4 | $0 (2020) |
| Janssen Biotech, Inc. | $2,638 | 28 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $2,400 | 4 | $0 (2023) |
| Verrica Pharmaceuticals Inc. | $1,300 | 1 | $0 (2023) |
| ABBVIE INC. | $689.54 | 35 | $0 (2024) |
| Galderma Laboratories, L.P. | $594.01 | 24 | $0 (2024) |
| Avita Medical Americas, LLC | $500.00 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,057 | 39 | Janssen Biotech, Inc. ($2,205) |
| 2023 | $19,966 | 56 | Sun Pharmaceutical Industries Inc. ($14,978) |
| 2022 | $10,462 | 49 | Sun Pharmaceutical Industries Inc. ($9,624) |
| 2021 | $680.10 | 35 | Allergan, Inc. ($209.32) |
| 2020 | $3,677 | 10 | Dr.Reddy's Laboratories,Inc. ($3,512) |
| 2019 | $327.68 | 10 | Sun Pharmaceutical Industries Inc. ($120.20) |
| 2018 | $11,332 | 23 | Celgene Corporation ($7,814) |
| 2017 | $14,188 | 74 | Celgene Corporation ($7,870) |
All Payment Transactions
296 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Immunology | ||||||
| 12/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: IMMUNOLOGY | ||||||
| 11/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $18.68 | General |
| 11/02/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $10.92 | General |
| Category: Dermatology | ||||||
| 11/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.18 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: FACIAL AESTHETICS | ||||||
| 10/16/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: DERMATOLOGY | ||||||
| 09/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.55 | General |
| Category: IMMUNOLOGY | ||||||
| 09/16/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: DERMATOLOGY | ||||||
| 09/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $32.44 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $152.52 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Dermatology | ||||||
| 08/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: IMMUNOLOGY | ||||||
| 06/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Consulting Fee | Cash or cash equivalent | $2,062.50 | General |
| Category: Immunology | ||||||
| 06/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $121.78 | General |
| Category: Immunology | ||||||
| 06/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.37 | General |
| Category: IMMUNOLOGY | ||||||
| 06/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: IMMUNOLOGY | ||||||
| 06/13/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $111.17 | General |
| Category: Dermatology | ||||||
| 06/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: IMMUNOLOGY | ||||||
| 05/07/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,760.00 | General |
| Category: Dermatology | ||||||
| 04/25/2024 | ABBVIE INC. | SKYRIZI (Biological), HUMIRA | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A TRIAL EVALUATING THE SAFETY AND EFFICACY OF ONCE DAILY TOPICAL TREATMENT WITH LEO 90100 AEROSOL FOAM IN ADOLESCENT SUBJECTS WITH PLAQUE PSORIASIS | LEO Pharma AS | $7,768 | 4 |
| Randomized,Doube-Blind, Placebo-Controlled, Multicenter, 24 week study to assess the Efficacy and Safety of PPC-06, extended release tablets in Moderate to Severe Plaque Psoriasis | Dr.Reddy's Laboratories,Inc. | $3,512 | 4 |
| Phase IIa study in patients with atopic dermatitis | Boehringer Ingelheim Pharmaceuticals, Inc. | $79.20 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 5,751 | 8,205 | $2.0M | $694,912 |
| 2022 | 23 | 2,400 | 3,087 | $675,555 | $267,404 |
| 2021 | 13 | 491 | 622 | $130,538 | $52,454 |
| 2020 | 13 | 557 | 703 | $132,297 | $47,772 |
Total Patients
9,199
Total Services
12,617
Medicare Billing
$1.1M
Procedure Codes
85
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,225 | 1,923 | $383,550 | $148,744 | 38.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 1,059 | 1,059 | $316,700 | $95,569 | 30.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 500 | 684 | $205,100 | $75,770 | 36.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 548 | 548 | $205,200 | $69,767 | 34.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 306 | 452 | $135,600 | $45,133 | 33.3% |
| 96910 | Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | Office | 2023 | 33 | 365 | $91,250 | $40,644 | 44.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 397 | 426 | $106,500 | $35,956 | 33.8% |
| Q4247 | Amniotext patch, per square centimeter | Office | 2023 | 12 | 66 | $39,460 | $26,076 | 66.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 263 | 402 | $80,400 | $19,899 | 24.8% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 28 | 32 | $47,422 | $16,792 | 35.4% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 170 | 232 | $30,160 | $10,871 | 36.0% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 28 | 31 | $23,010 | $9,876 | 42.9% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 16 | 17 | $17,000 | $9,771 | 57.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 76 | 80 | $20,000 | $9,002 | 45.0% |
| 10040 | Acne surgery | Office | 2023 | 64 | 81 | $20,250 | $8,614 | 42.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 118 | 131 | $13,100 | $6,607 | 50.4% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 12 | 14 | $13,630 | $5,369 | 39.4% |
| 11901 | Injection into skin growth, more than 7 growths | Office | 2023 | 42 | 95 | $23,750 | $5,320 | 22.4% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 21 | 21 | $11,178 | $5,048 | 45.2% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 17 | 19 | $9,120 | $4,592 | 50.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 76 | 99 | $24,750 | $4,533 | 18.3% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 37 | 40 | $10,000 | $4,509 | 45.1% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 30 | 36 | $10,800 | $4,383 | 40.6% |
| 17360 | Chemical treatment of acne | Office | 2023 | 16 | 34 | $8,500 | $3,805 | 44.8% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 78 | 103 | $20,600 | $3,700 | 18.0% |
About Dr. Robert Buka, MD
Dr. Robert Buka, MD is a Dermatology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427029180.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Buka, MD has received a total of $65,689 in payments from pharmaceutical and medical device companies, with $5,057 received in 2024. These payments were reported across 296 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($31,875).
As a Medicare-enrolled provider, Buka has provided services to 9,199 Medicare beneficiaries, totaling 12,617 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location New York, NY
- Active Since 01/31/2006
- Last Updated 06/04/2008
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1427029180
Products in Payments
- ILUMYA (Biological) $26,360
- Otezla (Drug) $15,575
- DOVONEX (Drug) $4,914
- TREMFYA (Drug) $2,527
- YCANTH (Drug) $1,300
- SKYRIZI (Biological) $503.10
- Recell (Device) $500.00
- VTAMA (Drug) $453.92
- Bimzelx (Biological) $314.22
- OPZELURA (Drug) $310.07
- DUPIXENT (Biological) $302.00
- EUCRISA (Drug) $280.04
- EPIDUO FORTE (Drug) $277.42
- BOTOX (Biological) $236.32
- SILIQ (Drug) $215.00
- Winlevi (Drug) $207.32
- SOOLANTRA (Drug) $182.72
- Topicort Spray 0.25% (Drug) $152.68
- Sotyktu (Drug) $149.75
- Ameluz (Drug) $148.11
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in New York
David Cohen, M.d, M.D
Dermatology — Payments: $3.1M
Dermatology $3.1M
Dr. Amy Wechsler, M.d, M.D
Dermatology — Payments: $2.8M
Dermatology $2.8M
Dr. Alexandra Golant, M.d, M.D
Dermatology — Payments: $2.7M
Dermatology $2.7M
Emma Guttman, Md, MD
Dermatology — Payments: $2.2M
Dermatology $2.2M
Dr. Joshua Zeichner, Md, MD
Dermatology — Payments: $2.1M
Dermatology $2.1M
Dr. Mark Lebwohl
Dermatology — Payments: $2.0M
Dermatology $2.0M